Develops eye drops for presbyopia.
Dec 2025Revenue $19.1M/yrExpenses $110M/yr
No trendCash runway ≈ 3 months from Jun 2026
Figures by year
When will LENZ Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $19.1M and expenses $110M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $19.1M | $110M | −$91.1M |
| Dec 2024 | $0.00 | $58.6M | −$58.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.